You have 9 free searches left this month | for more free features.

Chlorambucil

Showing 26 - 50 of 106

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Lymphocytic Leukemia Trial in Austria, Germany (Fludarabine, Chlorambucil)

Completed
  • Chronic Lymphocytic Leukemia
  • Vienna, Austria
  • +87 more
May 21, 2019

Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Chlorambucil, Obinutuzumab)

Terminated
  • Chronic Lymphocytic Leukemia
  • Santa Barbara, California
  • +17 more
Oct 19, 2018

Chronic Lymphocytic Leukemia Trial in Worldwide (Fludarabine, Cyclophosphamide, Rituximab)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Wien, Austria
  • +160 more
Sep 29, 2021

Chronic Lymphocytic Leukemia Trial in Germany (Obinutuzumab, Venetoclax, Acalabrutinib)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Bad Saarow, Germany
  • +29 more
May 4, 2022

Uveitis Trial in Worldwide (Adalimumab (ADA), Conventional immunosuppression (CON))

Recruiting
  • Uveitis
  • Adalimumab (ADA)
  • Conventional immunosuppression (CON)
  • Los Angeles, California
  • +27 more
Jun 16, 2022

B-Cell Chronic Lymphocytic Leukemia, B-Cell Chronic Lymphocytic Leukemia in Relapse (Diagnosis) Trial in Huixquilucan

Completed
  • B-Cell Chronic Lymphocytic Leukemia
  • B-Cell Chronic Lymphocytic Leukemia in Relapse (Diagnosis)
  • Huixquilucan, Estado De México, Mexico
    Grupo Cooperativo de Hemopatías Malignas
Feb 1, 2021

B-Cell Chronic Lymphocytic Leukemia Trial in Worldwide (Lenalidomide, Chlorambucil)

Completed
  • B-Cell Chronic Lymphocytic Leukemia
  • Escondido, California
  • +164 more
Jun 14, 2019

Lymphocytic Leukemia, Chronic Trial in Worldwide (obinutuzumab, rituximab, chlorambucil)

Completed
  • Lymphocytic Leukemia, Chronic
  • San Diego, California
  • +261 more
Aug 15, 2018

Lymphoma, Follicular Trial in United States (Bendamustine, Rituximab, Y-90 ibritumomab)

Completed
  • Lymphoma, Follicular
  • Scarborough, Maine
  • +3 more
Apr 27, 2021

Expression of CD19 Complex in Lymphoproliferative Disorders

Not yet recruiting
  • Lymphoproliferative Disorders
  • Flow cytometry
  • (no location specified)
Feb 2, 2021

Lymphocytic Leukemia, Chronic Trial in Worldwide (obinutuzumab, rituximab, chlorambucil)

Completed
  • Lymphocytic Leukemia, Chronic
  • San Diego, California
  • +261 more
Aug 15, 2018

Lymphocytic Leukemia, Chronic Trial in Worldwide (obinutuzumab, rituximab, chlorambucil)

Completed
  • Lymphocytic Leukemia, Chronic
  • San Diego, California
  • +261 more
Aug 15, 2018

Waldenstrom's Macroglobulinemia Trial in Athens, Rotterdam, Salamanca (Bortezomib, Rituximab, Dexamethasone)

Completed
  • Waldenstrom's Macroglobulinemia
  • Bortezomib, Rituximab, Dexamethasone
  • Athens, Attica, Greece
  • +3 more
Apr 27, 2021

Leukemia, Lymphocytic, Chronic Trial run by the NCI (rhIL-15, Obinutuzumab)

Terminated
  • Leukemia
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Mar 11, 2022

Chronic Lymphocyte Leukemia, Adult Patients Trial in Italy (Ibrutinib, Rituximab)

Active, not recruiting
  • Chronic Lymphocyte Leukemia
  • Adult Patients
  • Alessandria, Italy
  • +35 more
Oct 5, 2020

Safety of Chlorambucil + Rituximab in CLL Patients

Unknown status
  • CLL
  • +4 more
    • Ascoli Piceno, Italy
    • +19 more
    Mar 21, 2018

    Dermatomyositis, Adult Type Trial in New Orleans (Apremilast 30mg)

    Completed
    • Dermatomyositis, Adult Type
    • Apremilast 30mg
    • New Orleans, Louisiana
      Tulane University
    Jul 7, 2021

    Chronic Lymphocytic Leukemia- Binet Staging System Trial in Spain (Acalabrutinib 100 MG Oral Capsule)

    Recruiting
    • Chronic Lymphocytic Leukemia- Binet Staging System
    • Acalabrutinib 100 MG Oral Capsule
    • A Coruña, Spain
    • +20 more
    Jan 17, 2022

    Treatment Outcome of Uveitis in Autoimmune Diseases

    Unknown status
    • Autoimmune Uveitis
    • Corticosteroid Series
    • (no location specified)
    Mar 20, 2019

    Urothelial Carcinoma, Bladder Cancer, Urinary Bladder Tumors Trial run by the NCI (75 approved agents, COXEN)

    Completed
    • Urothelial Carcinoma
    • +2 more
    • 75 approved agents
    • COXEN
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Oct 14, 2020

    Chronic Lymphocytic Leukemia Trial in Brno, Hradec Králové

    Unknown status
    • Chronic Lymphocytic Leukemia
      • Brno, Czechia
      • +1 more
      Mar 15, 2019

      Lymphocytic Leukemia, Chronic Trial in Italy (rituximab [MabThera/Rituxan], chlorambucil)

      Completed
      • Lymphocytic Leukemia, Chronic
      • rituximab [MabThera/Rituxan]
      • chlorambucil
      • Catanzaro, Calabria, Italy
      • +19 more
      Jul 6, 2017

      Idiopathic Membranous Nephropathy Trial in Shanghai (Tacrolimus, Prednisone)

      Unknown status
      • Idiopathic Membranous Nephropathy
      • Shanghai, Shanghai, China
        Shanghai Xinhua Hospital affliated to Shanghai Jiao Tong Univers
      Apr 1, 2019

      Chronic Lymphocytic Leukemia Trial in Worldwide (Bendamustine, Chlorambucil, Cyclophosphamide)

      Completed
      • Chronic Lymphocytic Leukemia
      • Santa Fé, Argentina
      • +173 more
      Oct 24, 2019

      Chronic Lymphocytic Leukemia Trial in United States (Obinutuzumab, Chlorambucil)

      Completed
      • Chronic Lymphocytic Leukemia
      • Huntsville, Alabama
      • +18 more
      Mar 20, 2017